Mitotech's SkQ1 and its potential for treating age-related disorders discussed in Fierce Biotech publication

Dr. Lawrence Friedhoff, the CCO of Mitotech S.A., discussed potential of SkQ1 for treating age-related diseases in a recent article by Fierce Biotech. You can access the full article here:

Mitotech's SkQ1 targets mtROS, and a long list of age-related diseases